Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gartner Inc (IT) vs GeneDx Holdings Corp (WGS) Price & Performance

Gartner IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Gartner Inc vs GeneDx Holdings Corp — how do they compare? Gartner Inc trades at $187.27 (market cap $12.20B), while GeneDx Holdings Corp trades at $81.98 (market cap $2.32B). The key difference: Gartner Inc is far larger — about 5.3× GeneDx Holdings Corp's market cap. Which is the better fit depends on your goals.

ITWGS
Market Cap
$12.20B$2.32B
Sector
TechnologyTechnology
52-Week High
$264.09$167.51
52-Week Low
$125.68$34.51
Enterprise Value
$13.94B$2.35B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gartner Inc

Gartner (IT) trades at $185.6, up 0.42% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust profitability with a 69.63% gross margin and 12% net income margin, though revenue growth has moderated. Recent news highlights Q2 2026 earnings exceeding expectations and raised full-year EPS guidance, driving positive investor sentiment.

Outlook is supported by valuation discounts (P/E 16.69) and high ROE (113.58%), but risks include consulting segment weakness and negative net cash flow trends. Analysts are mixed with a $172.80 consensus target, suggesting cautious optimism amid execution challenges.

GeneDx Holdings Corp

GeneDx Holdings Corp. (WGS) trades at $77.08, up 10.76% today, showing strong momentum despite negative profitability metrics. The stock exhibits bullish technical signals with support at $72 and resistance at $80. Recent Q2 2026 earnings beat expectations with $0.01 EPS versus -$0.19 estimate, while revenue reached $114.4 million. However, the company faces significant challenges with a -23.4% net income margin and ongoing securities class action litigation.

Investment outlook remains cautiously optimistic given strong analyst support (90.9% buy rating) and $79.25 consensus price target. Key opportunities include growing genomic testing volumes and improved operational efficiency, while risks center on profitability challenges, legal liabilities, and high valuation multiples that may not justify current fundamentals.

Returns comparison

Trailing returns across standard periods

About Gartner Inc

Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.

Read more on IT

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS